• Molecular NameDeserpidine
  • SynonymDeresperine; Desepridine; Deserpidin; Deserpidina [INN-Spanish]; Deserpidinum [INN-Latin]; Deserpine; Desmethoxyreserpine
  • Weight578.662
  • Drugbank_IDDB01089
  • ACS_NO131-01-1
  • Show 3D model
  • LogP (experiment)3.788
  • LogP (predicted, AB/LogP v2.0)4.05
  • pkaN/A
  • LogD (pH=7, predicted)3.91
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.24
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors1
  • No.of HBond Acceptors10
  • No.of Rotatable Bonds9
  • TPSA108.55
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antihypertensive drug related to reserpine.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include dizziness or drowsiness (severe), flushing of skin, pinpoint pupils of eyes and slowed pulse.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A